Clinical trial · Observational
Mood Disorders Bladder Cancer
Evaluation of Mood Disorders in Bladder Cancer Patients and Their Primary Caregivers
NCT04036877CI-TRIAL-00082274completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a cross-sectional study evaluating mood disorders in bladder cancer patients and their caregivers across the bladder cancer trajectory
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mood Disorder Assessment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- Severity of depression in bladder cancer patients and their caregivers: Patient-Health Questionnaire-9
- timeFrame
- Data will be assessed through study completion, on average one year
- description
- Assessed using Patient-Health Questionnaire-9. A standard questionnaire with 9 questions. Score 5-9 is minimal symptoms, 10-14 is minor depression, 15-19 is major depression moderately severe, and 20-27 is severe major depression.
- measure
- Severity of anxiety in bladder cancer patients and their caregivers: Generalized Anxiety Disorder-7
- timeFrame
- Data will be assessed through study completion, on average one year
- description
- Assessed using Generalized Anxiety Disorder-7. A standard questionnaire composed of seven questions with scores ranging from 0 to 21. A score between 5 and 9 indicates mild anxiety, a score between 10 and 14 indicates moderate anxiety, and a score 15 or above indicates severe anxiety.
- measure
- Health-related quality of life in bladder cancer patients and their caregivers: Short Form-12
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients or caregiver of patient with a histologic diagnosis of bladder cancer of the following subtypes, urothelial carcinoma, adenocarcinoma, or squamous cell carcinoma, within 24 months of survey administration and received treatment at the University of Kansas Health System * ≥ 18 years of age * Have a patient-designated primary informal/family caregiver * Able to speak and read English * Willing and able to provide informed consent * Functioning telephone number or access to one Exclusion Criteria: * Patients or caregivers of patients with metastatic bladder cancer * Patients who are unable to designate a primary caregiver * Patients and caregivers who do not both consent to study participation
References
Publications (0)
Data not yet available
No reference posted for this study.